Experimental and clinical research of dendritic cell and syngeneic immunotherapy of brain glioma

Chinese-German Journal of Clinical Oncology

Volumn 3, Issue 3, 2004, Pages 147-150

  Niu, Hongquan ^a   Dong, Zhen ^a   Dong, Fangyong ^a   Zhang, Tao ^a   Lei, Ting ^a   Xue, Delin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Brain glioma; Dendritic cell; Immunotherapy

Indexed keywords

EID: 44249105673     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-003-0189-5     Document Type: Article

References (10)

1. Parney IF, Hao C, Petruk KC. Glioma immunology and immunotherapy. Neurosurgery, 2000, 46: 778-791.
2. Okada H, Tahara H, Shurin MR, et al. Bone marrowderived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms. Int J Cancer. 1998, Oct 5; 78: 196-201.
3. Heimberger AB, Crotty LE, Archer GE, et al. Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol, 2000, 103: 16-25.
4. Ni HT, Spellman SR, Jean WC, et al. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neurooncol, 2001, 51: 1-9.
5. Kikuchi T, Akasaki Y, Irie M, et al. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother, 2001, 50: 337-344.
6. Yoshida S, Morii K, Watanabe M, et al. The generation of anti-tumoral cells using dentriticcells from the peripheral blood of patients with malignant brain tumors. Cancer Immunol Immunother, 2001, 50: 321-327.
7. Yu JS, Wheeler CJ, Zeltzer PM, et al. Vaccination of malignant glioma patients with peptide pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res, 2001, 61: 842-847.
8. Liau LM, Black KL, Prins RM, et al. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg, 1999 Jun, 90: 1115-1124.
9. Oyama T, Ran S, Ishida T, et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol, 1998, 160: 1224-1232.
10. Allavena P, Piemonti L, Longoni D, et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol, 1998, 28: 359-369